Poly Medicure Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Acquisition of Subsidiary
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Poly Medicure's wholly owned subsidiary, Polymed Brazil LTDA, has acquired 100% equity in MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA, making it a step-down subsidiary effective April 29, 2026. The total cash consideration is Brazilian Reais (R$) 180,000 (roughly ₹27-28 lakhs). MEDYNEO is a newly registered entity (July 2025) with no past operations, employees, or turnover, but holds all the necessary licenses, permits, and registrations for importing and commercializing medical devices in Brazil. The deal is not a related party transaction. In essence, this is a strategic, low-cost acquisition aimed at giving Poly Medicure ready access to Brazil's medical device market through an existing licensed entity.
Minimal immediate financial impact given the small deal size, but strategically important as it gives Poly Medicure a quick entry into the Brazilian medical devices market with all regulatory licenses already in place, potentially enabling future revenue growth from that geography.